These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medical management of the hypercalcemia of malignancy. Deftos LJ; Neer R Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568 [No Abstract] [Full Text] [Related]
4. Therapy of malignancy-associated hypercalcemia: 1983. Stewart AF Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignancy associated hypercalcemia]. Tai N; Inoue D Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875 [TBL] [Abstract][Full Text] [Related]
10. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.]. Tai N; Inoue D Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007 [TBL] [Abstract][Full Text] [Related]
11. Overview of hypercalcemia of malignancy. Solimando DA Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221 [TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Mosekilde L; Eriksen EF; Charles P Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hypercalcaemia of malignancy. Heath DA Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893 [TBL] [Abstract][Full Text] [Related]
15. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357 [TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of malignant hypercalcemia]. Eto S; Nakano Y; Okada Y Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844 [TBL] [Abstract][Full Text] [Related]
18. Modern management of malignant hypercalcemia. Legrand SB Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679 [TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia and cancer: an update. Murray TM; Josse RG; Heersche JN Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555 [TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Wysolmerski JJ; Broadus AE Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]